AKT3

From WikiMD's WELLNESSPEDIA

AKT3

AKT3 is a serine/threonine-protein kinase that is encoded by the AKT3 gene in humans. It is a member of the AKT family of kinases, which are involved in various cellular processes including metabolism, proliferation, cell survival, growth, and angiogenesis.

Structure[edit]

AKT3, like other members of the AKT family, consists of three main domains: the pleckstrin homology (PH) domain, the kinase domain, and the regulatory domain. The PH domain is responsible for binding to phosphoinositides, which localizes AKT3 to the plasma membrane where it can be activated.

Function[edit]

AKT3 plays a crucial role in the PI3K/AKT signaling pathway, which is a key regulator of many cellular processes. This pathway is activated by various growth factors and hormones, leading to the activation of AKT3 through phosphorylation. Once activated, AKT3 can phosphorylate a wide range of substrates involved in cell cycle progression, apoptosis, and metabolism.

Clinical Significance[edit]

AKT3 has been implicated in several types of cancer, including glioblastoma, breast cancer, and prostate cancer. Overexpression or hyperactivation of AKT3 can lead to increased cell survival and proliferation, contributing to tumorigenesis. Inhibitors targeting the PI3K/AKT pathway are being explored as potential therapeutic agents in cancer treatment.

Research[edit]

Recent studies have focused on the role of AKT3 in the brain, where it is thought to be involved in neurodevelopment and neuroprotection. Mutations in the AKT3 gene have been associated with developmental disorders such as megalencephaly and polymicrogyria.

Also see[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.